ArticleJournal of virology2025
Primary envelopment of Kaposi's sarcoma-associated herpesvirus at the nucleoplasmic reticulum.
Article in Journal of virology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Herpesvirus egress begins with primary envelopment of newly assembled capsids at the inner nuclear membrane (INM). Primary envelopment has been observed at the peripheral INM as well as nuclear infoldings. Nuclear infoldings from invaginations of the INM are Type-I nucleoplasmic reticulum (NR), whereas infoldings of both INM and outer nuclear membrane (ONM) are Type-II NR. Here, we report that Kaposi's sarcoma-associated herpesvirus (KSHV) reactivation from latency and lytic cycle progression correlates with increases in both types of NR, but primary envelopment is restricted to peripheral INM and Type-I NR. These Type-I NR structures co-localized with puncta containing CTP:phosphocholine cytidylyltransferase (CCTα), the enzyme that catalyzes the rate-limiting step in phosphatidylcholine (PtdCho) synthesis that drives the IMPORTANCE: Herpesvirus capsids assemble in the cell nucleus but are too large to exit via nuclear pores. Instead, they bud into the inner nuclear membrane to acquire a provisional lipid envelope that is shed through fusion with the outer nuclear membrane, delivering the capsid to the cytoplasm for subsequent steps in assembly and egress. These nuclear membranes are dynamic, with the ability to fold into invaginations that access the nuclear interior. Here, we demonstrate that during Kaposi's sarcoma-associated herpesvirus (KSHV) replication, nuclear membrane infolding increases, coinciding with recruitment of a host enzyme required for PtdCho synthesis at these sites. We observed accumulation of KSHV capsids at infoldings of the inner nuclear membrane and tracked the association and trafficking of fluorescent viral particles through these structures by live cell microscopy. This complements a more well-established mechanism of KSHV egress at the nuclear periphery and suggests versatility in nuclear egress mechanisms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.